Ipratropium bromide versus short acting beta‐2 agonists for stable chronic obstructive pulmonary disease

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a condition associated with high morbidity, mortality and cost to the community. Patients often report symptomatic improvement with short‐acting beta‐2 agonists (SABA) and anticholinergic bronchodilator medications, and both are recommended...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cochrane Database Syst Rev
Hlavní autoři: Appleton, Sarah, Jones, Terry, Poole, Phillippa, Pilotto, Louis, Adams, Robert, Lasserson, Toby J, Smith, Brian J, Muhammed, Julia
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Ltd 2006
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6513456/
https://ncbi.nlm.nih.gov/pubmed/16625543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001387.pub2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky